Trientine hydrochloride 250 MG Oral Capsule

INDICATIONS AND USAGE Trientine hydrochloride capsules are indicated in the treatment of patients with Wilson's disease who are intolerant of penicillamine. Clinical experience with trientine hydrochloride capsules is limited and alternate dosing regimens have not been well-characterized; all endpoints in determining an individual patient's dose have not been well defined. Trientine hydrochloride capsules and penicillamine cannot be considered interchangeable. Trientine hydrochloride capsules should be used when continued treatment with penicillamine is no longer possible because of intolerable or life endangering side effects. Unlike penicillamine, trientine hydrochloride capsules are not recommended in cystinuria or rheumatoid arthritis. The absence of a sulfhydryl moiety renders it incapable of binding cystine and, therefore, it is of no use in cystinuria. In 15 patients with rheumatoid arthritis, trientine hydrochloride capsules was reported not to be effective in improving any clinical or biochemical parameter after 12 weeks of treatment. Trientine hydrochloride capsules are not indicated for treatment of biliary cirrhosis.

Par Pharmaceutical, Inc.

FDA Reported Adverse Reactions
`[1] dyspnoea` `[2] fatigue` `[3] nausea` `[4] diarrhoea` `[5] dizziness` `[6] drug ineffective` `[7] headache` `[8] asthenia` `[9] fall` `[10] pain`

4 years ago

CAPSULE BROWN PAR 060

HOW SUPPLIED

TRIENTINE HYDROCHLORIDE capsules, USP are light brown opaque size ‘1’ capsule imprinted "PAR" on cap and “060” on the body containing white to off white powder. They are supplied as follows: NDC 49884-060-01 in bottles of 100 Storage Keep container tightly closed. Store at 2° to 8°C (36° to 46°F). Dist. by: Par Pharmaceutical Chestnut Ridge, NY 10977 U.S.A. Mfg. by: Par Formulations Private Limited, 9/215, Pudupakkam, Kelambakkam - 603 103. Made in India Mfg. Lic. No.: TN00002121 OS060-01-74-01 Issued: 06/2017

More pills like CAPSULE PAR 060

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

Trientine hydrochloride 250 MG Oral Capsule

FDA Reported Adverse Reactions [1] dyspnoea [2] fatigue [3] nausea [4] diarrhoea [5] dizziness [6] drug ineffective [7] headache [8] asthenia [9] fall [10] pain

CAPSULE BROWN PAR 060

More pills like CAPSULE PAR 060

FDA Reported Adverse Reactions
`[1] dyspnoea` `[2] fatigue` `[3] nausea` `[4] diarrhoea` `[5] dizziness` `[6] drug ineffective` `[7] headache` `[8] asthenia` `[9] fall` `[10] pain`